布地奈德联合氨溴索雾化吸入辅助治疗毛细支气管炎

• 作 者: 张龙英 姚其娟
• 机 构: 滨海县人民医院儿科,
• 出 处: 江苏医药
• 发表日期: 2015年07期
• 关键词: @@

目的观察布地奈德联合氨溴索雾化吸入辅助治疗毛细支气管炎的临床疗效。方法80例毛细支气管炎患儿均分为治疗组和对照组,两组均给予常规治疗。治疗组在对照组基础上给予布地奈德联合氨溴索雾化吸入。比较两组患儿临床疗效。结果治疗组总有效率为97.5%,高于对照组的87.5%(P<0.05)。结论布地奈德联合氨溴索雾化吸入辅助治疗毛细支气管炎临床疗效显著且安全、方便,值得临床推广。

Objective To observe the clinical efficacy of budesonide combined with ambroxol inhalation in the treatment of bronchiolitis. Methods 80 cases of children with bronchiolitis were divided into treatment group and control group, both groups were given routine treatment. The treatment group was given budesonide combined with ambroxol inhalation on the basis of the control group. The clinical efficacy of two groups were compared. Results The total effective rate was 97.5% in the treatment group, 87.5% higher than that in the control group (P <0.05). Conclusion Budesonide combined with ambroxol inhalation in the treatment of bronchiolitis has significant clinical efficacy and safety, convenience, and worthy of clinical promotion.